Skip to main content

RegMedNet is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Our journals
    • Our journals
    • Journal content
    • Journal articles

    Follow us on social media

  • Topics
    • CAR-T
      • Stem cells
      • Cell therapy
      • Gene therapy
      • Gene editing
    • Cancer
      • Preclinical research
      • Tissue engineering
      • 3D printing
      • Biobanking
    • Clinical trials & funding
      • Manufacturing & scale-up
      • Regulation & policy
      • Industry developments

    Follow us on social media

  • Explore content
    • News
      • The week in cell therapy
      • Interviews
      • Opinion
      • Report
      • App Notes & White Papers
    • Spotlights
      • In Focus
      • eBooks
      • Webinars
      • Podcasts
      • Videos
      • Infographics
    • Find a partner
      • Events
      • Events coverage
      • The Glossary for Advanced Therapies

    Follow us on social media

  • Register
Spotlight exclusive: Expert insights on GMP media, xeno-free solutions and raw material management Read the interview!

iPSC expansion in the Quantum Flex cell expansion system small bioreactor

28 Jan 2025
Written by Terumo BCT
App Notes & White Papers iPSCs Manufacturing & scale-up

Discover the efficiency and flexibility that can be achieved when expanding iPSCs in the Quantum Flex small bioreactor.

This poster is part of the RegMedNet In Focus on scaling iPSC cultures. Discover expert opinions on this topic by visiting our feature homepage.

iPSC Expansion_ Quantum Flex_ Summary Sheet


This content was provided by Terumo Blood and Cell Technologies.

Top content

  • Cell therapy weekly: BLA submission planned for Huntington’s gene therapy AMT-130
  • eBook | Viral and non-viral gene delivery approaches
  • Building a consortium to accelerate stem cell models for drug discovery

Related tags

Bioreactor cell expansion iPSCs Terumo BCT
Previous article Next article

Related articles

19 FEB 2021 NEWS
Cell therapy weekly: Kymriah™ shows long-lasting remissions in non-Hodgkin lymphomas
24 MAR 2022 APP NOTES & WHITE PAPERS
Production of AAV using the AAV-MAX system in a 3 L stirred-tank bioreactor
cell and gene therapy
22 JAN 2021 NEWS
Cell therapy weekly: NICE recommends pioneering CAR-T therapy for patients with lymphoma
4 MAR 2021 NEWS
Analysis of iPSCs allows identification of disease-associated genetic variations
16 SEP 2020 NEWS
First stem cells discovered to produce placenta cells
7 SEP 2022 NEWS
New function of immune cells in liver regeneration discovered
  • About
  • Advertising & Sponsorship
  • Expert Panel
  • Permissions & content ownership policy
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

RegMedNet is powered by Taylor & Francis Group

RegMedNet, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 RegMedNet